Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

leva Pelvic Health System

K-Number: K213913 · 2022-06-30

ApplicantRenovia, Inc.
Decision Date2022-06-30
Product CodeHIR
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

leva Pelvic Health System is a medical device manufactured by Renovia, Inc.. It received FDA 510(k) clearance on 2022-06-30 under approval number K213913. The device is classified under product code HIR. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the leva Pelvic Health System?

leva Pelvic Health System is a medical device that received FDA 510(k) clearance on 2022-06-30. It is manufactured by Renovia, Inc.. The 510(k) number is K213913.

When was leva Pelvic Health System approved by the FDA?

leva Pelvic Health System received FDA 510(k) clearance on 2022-06-30, under approval number K213913.

What company makes leva Pelvic Health System?

leva Pelvic Health System is manufactured by Renovia, Inc..

What is the FDA product code for leva Pelvic Health System?

The FDA product code for leva Pelvic Health System is HIR.

Related Clinical Trials

NCT06727942 Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes RECRUITING NCT01174108 Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells RECRUITING NCT06642935 A Study to Explore Improved Features and a Simplified Treatment Approach for a Totally Implantable Cochlear Implant (TICI) Research System in Adults With Severe Hearing Loss ACTIVE_NOT_RECRUITING NCT07544654 DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy NOT_YET_RECRUITING NCT07607899 Virtual Reality for Pain and Well-Being in Older Adults NOT_YET_RECRUITING NCT02703207 Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD RECRUITING

Related PubMed Literature

PMID: 42056377 Signal detection of adverse events in medical devices using natural language processing: a case study in pelvic mesh. Scientific reports (2026) PMID: 41915995 Inflammation-metabolism-fibrosis axis: mechanisms and therapeutic strategies targeting the chronicity of pelvic inflammatory disease. International immunopharmacology (2026) PMID: 41887630 Capacity building for ethical use of artificial intelligence in health: protocol for a scoping review of training initiatives and gaps in Africa. BMJ open (2026) PMID: 41879133 Medical Device Regulation - Who Does the FDA Serve? The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2026)

Other Devices by Renovia, Inc.

K180637leva Pelvic Floor Trainer K192270LEva Pelvic Digital Health System K212495Leva Pelvic Health System

Related Devices (Code: HIR)

K160758PeriCoach OTCAnalytica, Ltd. K171896Feminine Personal Trainer (FPT)Ralston Group K162689Vibrance Pelvic TrainerBioinfinity (M) Sdn. Bhd. K180637leva Pelvic Floor TrainerRenovia, Inc. K192270LEva Pelvic Digital Health SystemRenovia, Inc. K193364Intimate Rose Kegel Exercise SystemPlus EV Holdings Dba Intimate Rose

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑